SINGAPORE GENERAL HOSPITAL
- Country
- 🇸🇬Singapore
- Ownership
- -
- Established
- 1821-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
241
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (178 trials with phase data)• Click on a phase to view related trials
Pain Relief in Women Undergoing Oocyte Retrieval (OR) With Electro-acupuncture (EA) or Conscious Sedation (CS) in a Single Assisted Reproduction Centre.
- Conditions
- Pain Intensity Assessment
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT07041632
- Locations
- 🇸🇬
Centre for Assisted Reproduction, Singapore, Singapore
Trial of Mobile External Defibrillator for Out-of-hospital Cardiac Arrest in Singapore.
- Conditions
- Out-of-hospital Cardiac Arrest (OHCA)
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT07042061
A Randomised Controlled Trial Comparing the Efficacy of Ultrasound-guided Hydrodilatation With Intra-articular Corticosteroid Injection in the Treatment of Adhesive Capsulitis.
- Conditions
- Adhesive Capsulitis, Shoulder
- First Posted Date
- 2025-05-23
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06987929
- Locations
- 🇸🇬
Autoimmunity and Rheumatology Centre, Singapore, Singapore
Be Right! Back: An Artificial Intelligence Enabled Mobile Application for Patients With Low Back Pain
- Conditions
- Low Back Pain
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06973915
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
Assessing the Feasibility of the Patient-Reported Outcomes Based Model for Community Care of Patients With Axial Spondyloarthritis Via a Type 1 Pilot Hybrid Effectiveness-Implementation Trial Using the RE-AIM Framework
- Conditions
- Axial Spondyloarthritis
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Singapore General Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT06968247
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
- Prev
- 1
- 2
- 3
- 4
- 5
- 48
- Next
News
Groundbreaking Histotripsy Cancer Treatment Trials to Begin in Singapore by 2025
• Singapore will commence clinical trials of histotripsy, a non-invasive ultrasound-based cancer treatment that uses microbubbles to destroy tumors without surgery or radiation, starting in the second half of 2025. • The Li Ka Shing Foundation and Temasek Trust have committed S$12 million to bring two histotripsy machines to Singapore, with initial trials focusing on 40 liver cancer patients before expanding to kidney and pancreatic cancers. • Histotripsy, which received FDA approval for liver tumors in October 2023, has already treated approximately 50 cancer patients in Hong Kong and over 1,000 in the US, with researchers noting its potential to stimulate immune responses against non-targeted tumors.